p27 protein and cancers of the gastrointestinal tract and liver: An overview

Journal of Clinical Gastroenterology

Volumn 37, Issue 1, 2003, Pages 23-27

  Chetty, Runjan ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cancer; Cell cycle; Gastrointestinal tract; Liver; p27

Indexed keywords

PROTEIN P27;

BARRETT ESOPHAGUS; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE; CELLULAR DISTRIBUTION; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 0037599433     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200307000-00008     Document Type: Review

References (47)

1. Sherr CJ. G1 Progression: Cycling on Cue. Cell. 1994;79:551-555.
2. Motokura T, Arnold A. Cyclins and Oncogenesis. Biochema et Biophysica Acta. 1993;1155:63-78.
3. Kim YT, Cho NH, Park SW, et al. Underexpression of Cyclin-Dependent Kinase (CDK) Inhibitors in Cervical Carcinoma. Gynecol Oncol. 1998;71:38-45.
4. kip 1 chromosomal mapping to 12p 12-12p 13.1 and absence of mutations in human tumors. Cancer Res. 1995;55:1211-1214.
5. Koff A, Ohtsuki M, Polyak K. et al. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science. 1993;260:536-539.
6. Kip 1, a cyclin-Cdk inhibitor, links transforming growth factor-b and contact inhibition to cell cycle arrest. Genes Dev. 1994:8:9-22.
7. Kip 1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994;78:59-66.
8. Slingerl JM, Hengst L, Pan C-H, et al. A novel inhibitor of cyclin-cdk activity detected in Transforming Growth Factor β-arrested epithelial cells. Mol Cell Biol. 1994;14:3683-3694.
9. Hengst L, Dulic V, Slingerl J, et al. A cell cycle regulated inhibitor of cyclin dependent kinases. Proc Natl Acad Sci. 1994:91:5291-5294.
10. Morosetti R. Kawamata N, Gombart AF, et al. Alterations of the p27/Kip 1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood, 1995;86:1924-1930.
11. Spirin KS. Simpson JF, Takenchi S. et al. p27/Kip 1 mutation found in breast cancer. Cancer Res. 1996;56:2400-2404.
12. kip 1 on resistance of tumor cells to anti-cancer agents. Nature Med. 1996;2:1204-1210.
13. kip 1 gene and trisomy 12 in a subset of human pituitary adenomas. J Clin Endocrinol Metab. 1997;82:3141-3147.
14. kip 1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313-323.
15. Itami A, Shimada Y, Watanabe G. et al. Prognostic value of p27 (Kip 1) and cyclin D 1 expression in esophageal cancer. Oncology. 1999;57:311-317.
16. Kagawa Y, Yoshida K, Hirai T, et al. Significance of the expression of p27 Kip 1 in esophageal squamous cell carcinomas. Dis Esophagus. 2000;13:179-184.
17. Ohashi Y, Sasano H, Yamaki H. et al. Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma. Anticancer Res. 1999;19:1843-1848.
18. Shamma A, Doki Y, Tsujinaka T. et al. Loss of p27 (KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology. 2000;58:152-158.
19. Shibata H. Matsubara O, Wakiyama H, et al. The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus. Pathol Res Pract. 2001;197:157-164.
20. Ellis FH Jr, Xu X, Kulke MH. et al. Malignant transformation of the esophageal mucosa is enhanced in p27 knockout mice. J Thorac Cardiovasc Surg. 2001;122:809-814.
21. Singh SP. Lipman J, Goldman H, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 1998;58:1730-1735.
22. Yasui W, Kudo Y, Semba S. et al. Reduced expression of cyclin-dependent kinase inhibitor p27Kip 1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res. 1997;88:625-629.
23. Mori M, Mimori K, Shiraishi T, et al. p27 expression and gastric carcinoma. Nature Med. 1997;3:593.
24. Ohtani M, Isozaki H, Fujii K, et al. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip 1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma. Cancer. 1999;85:1711-1718.
25. Kwon OJ, Kang HS, Suh JS, et al. The loss of p27 protein has an independent prognostic significance in gastric cancer. Anticancer Res. 1999;19:4215-4220.
26. Migaldi M, Zunarelli E, Sgambato A, et al. p27Kip1 expression and survival in NO gastric carcinoma. Pathol Res Pract. 2001;197:231-236.
27. Liu XP, Kawauchi S. Oga A. et al. Combined examination of p27 (Kipl) p21, (Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma. Histopathology. 2001;39:603-610.
28. Kim DH, Lee HI, Nam ES. et al. Reduced expression of the cell-cycle inhibitor p27Kipl is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology. 2000;36:245-251.
29. Wiksten JP. Lundin J, Nordling S, et al. The prognostic value of p27 in gastric cancer. Oncology. 2002;63:180-184.
30. Feakins RM, Mulcahy HE, Quaglia A. et al. Cancer. 2000;89:1684-1691.
31. Thomas GV, Szigeti K, Murphy M, et al. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastasis. Am J Pathol. 1998;153:681-687.
32. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997;3:231-234.
33. Palmqvist R, Stenling R, Oberg A, et al. Prognostic significance of p27(Kip1) expression in colorectal cancer: a clinico- pathological characterization. J Pathol. 1999;188:18-23.
34. Sgambato A, Ratto C, Faraglia B, et al. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kipl) in human colon cancer. Mol Carcinogenesis. 1999;26:172-179.
35. Gunther K, Jung A, Volker U, et al. p27(kipl) expression in rectal cancer correlates with disease-free survival. J Surg Res. 2000;92:78-84.
36. Liu DF, Ferguson K, Cooper GS, et al. P27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer. J Clin Lab Anal. 1999;13:291-295.
37. Tenjo T, Toyoda M, Okuda J, et al. Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology. 2000;58:45-51.
38. Yao J, Eu KW, Seow-Choen F, et al. Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas. Int J Cancer. 2000;89:213-216.
39. Zhang H, Sun XF. Loss of p27 expression predicts poor prognosis in patients with Dukes' D stage or proximal colorectal cancer. Int J Oncol. 2001;19:49-52.
40. Tannapfel A. Grund D, Katalinic A, et al. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma, Int J Cancer. 2000;89:350-355.
41. Fiorentino M, Altimari A, D'Errico A, et al. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin Cancer Res. 2000;6(10):3966-72.
42. Qin LF, Ng IO. Expression of p27 (KIPI) and p21 (WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis. Hum Pathol. 2001;32:778-784.
43. Fiorentino M, Altimari A, D'Errico A, et al. Low p27 expression is an independent predictor of survival for patients with either hilar or peripheral intrahepatic cholangiocarcinoma. Clin Cancer Res. 2001;7:3994-3999.
44. Brotto M, Finegold MJ. Distinct patterns of p27/KIP1 gene expression in hepatoblastoma and prognostic implications with correlation before and after chemotherapy. Hum Pathol. 2002;33:198-205.
45. Chetty R. Cyclin E and p27/kipl: two proteins on a see-saw or another false dawn? Histopathology. 2002;40:393-394.
46. Chetty R. Cyclin E and p27: their putative roles as prognostic markers. Curr Diagn Pathol. 2002;8:289-296.
47. Opalka B, Dickopp A, Kirch HC. Apoptotic genes in cancer therapy. Cells Tissues Organs. 2002;172:126-132.